$12.34
-0.57-4.42%
At Close: -
15 minutes delayed
Perspective Therapeutics
CATXAMEX
Perspective Therapeutics (CATX) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestPerspective Therapeutics (AMEX:CATX) Stock Quotes, Forecast and News Summary
Perspective Therapeutics Stock (AMEX: CATX) stock price, news, charts, stock research, profile.
| Open | $13.00 |
| Close | $12.34 |
| Volume / Avg. | 814.02K / 871.24K |
| Day Range | 12.11 - 13.04 |
| 52 Wk Range | 2.05 - 19.05 |
| Market Cap | $831.89M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | AMEX |
| RSI | 51 |
| Short Interest | 7.78% |
| Days to Cover | 2.1 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Perspective Therapeutics Inc
Sector
Health Care
Industry
Biotechnology
Perspective Therapeutics Inc is a medical technology and radiopharmaceutical company that is pioneer...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Perspective Therapeutics (CATX) stock?
You can purchase shares of Perspective Therapeutics (AMEX:CATX) through any online brokerage.
Who are Perspective Therapeutics (CATX) competitors?
Other companies in Perspective Therapeutics’s space includes: Immunome (NASDAQ:IMNM), ARS Pharmaceuticals (NASDAQ:SPRY), 89bio (NASDAQ:ETNB), Humacyte (NASDAQ:HUMA) and Cogent Biosciences (NASDAQ:COGT).
What is the target price for Perspective Therapeutics (CATX) stock?
There is no analysis for Perspective Therapeutics.
What is the forecast for Perspective Therapeutics (CATX) stock?
Perspective Therapeutics has a consensus price target of $2.08.
Current stock price for Perspective Therapeutics (CATX)?
The stock price for Perspective Therapeutics (AMEX: CATX) is $12.45 last updated July 15, 2024 at 7:59 PM EDT.
Does Perspective Therapeutics (CATX) pay a dividend?
There are no upcoming dividends for Perspective Therapeutics.
When is Perspective Therapeutics (AMEX:CATX) reporting earnings?
Perspective Therapeutics’s Q2 earnings are confirmed for Thursday, August 15, 2024.
Is Perspective Therapeutics (CATX) going to split?
There is no upcoming split for Perspective Therapeutics.
What sector and industry does Perspective Therapeutics (CATX) operate in?
Perspective Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.